Those with type 1 schizophrenia typically had more positive symptoms, such as changes in behavior caused by hallucinations or delusions. People diagnosed with type 2 were often more withdrawn and ...

At the Institute of Mental Health (IMH), almost 60 per cent to 70 per cent of patients with schizophrenia make a good ...

Explore the reality of schizophrenia by debunking seven myths and offering compassionate insights into this complex mental ...

As per the Brain and Behavior Research Foundation, it combines two compounds called xanomeline and trospium chloride. This is ...

Schizophrenia is a serious mental disorder that affects around 1% of the world’s population. Researchers of the University of ...

After the Phase II failure of its lead asset from Cerevel, AbbVie is resetting expectations and narrowing the clinical ...

The acute phase of schizophrenia is the florid psychotic phase, during which the patient exhibits acute symptoms--for example, severe delusions and/or hallucinations (positive symptoms ...

There are as yet no effective drugs for negative symptoms like social withdrawal and lack of motivation. Read more at ...

Usually described as a splitting or multiple personality disorder, the concept of schizophrenia is not entirely but rather a ...

Boehringer said the GPR52 agonists have the potential to tackle the gamut of symptoms in schizophrenia, not only positive symptoms like delusions and hallucinations, which respond to current drugs ...

Boehringer Ingelheim announced that its schizophrenia drug, iclepertin, did not achieve statistically significant ...

LB Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing novel therapies for the treatment of psychiatric diseases including schizophrenia, today announced positive topline ...